CD38 and plasma cell myeloma: Dermal fibroblasts activated by contact with multiple myeloma RPMI 8226 cells induce growth arrest and alter the expression of CD38, CD45, and CD138 in myeloma cells consistent with dedifferentiation, inflammation, and progression toward dormancy [104].